During the past decade, Universitätsklinikum Freiburg, Klinik für Augenheilkunde conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Adenovir Pharma AB" with 1 trials sponsored, "Dompé Farmaceutici S.p.A" with 1 trials sponsored, "LumiThera, Inc." with 1 trials sponsored and "STZ eyetrial" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator, "TFS Trial Form Support" with 1 trials as a collaborator and "University Hospital Tuebingen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde" are "Drug" (13 trials), "Other" (4 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (7 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Lampalizumab" (2 trials) and "APD-209 Eye drops" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Freiburg, Klinik für Augenheilkunde". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Universitätsklinikum Freiburg, Klinik für Augenheilkunde, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Freiburg, Klinik für Augenheilkunde, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".